High-Dose Therapy for Follicular Lymphoma Revisited: Not If, but When?
- 1 November 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (21), 3894-3896
- https://doi.org/10.1200/jco.2003.07.981
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP TrialJournal of Clinical Oncology, 2003
- Prolonged Single-Agent Versus Combination Chemotherapy in Indolent Follicular Lymphomas: A Study of the Cancer and Leukemia Group BJournal of Clinical Oncology, 2003
- Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2002
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa geneBlood, 2002
- Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMTBritish Journal of Haematology, 1999
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular LymphomaNew England Journal of Medicine, 1993
- Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.BMJ, 1978
- CLINICAL EVALUATION OF CB 1348 IN MALIGNANT LYMPHOMA AND RELATED DISEASESAnnals of the New York Academy of Sciences, 1958
- Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant LymphomaBMJ, 1955